{"id":23664,"date":"2024-11-22T08:26:24","date_gmt":"2024-11-22T13:26:24","guid":{"rendered":"https:\/\/medicarereport.org\/?p=23664"},"modified":"2024-11-22T08:26:25","modified_gmt":"2024-11-22T13:26:25","slug":"florida-gov-desantis-canadian-drug-import-plan-goes-nowhere-after-fda-approval","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=23664","title":{"rendered":"Florida Gov. DeSantis\u2019 Canadian Drug Import Plan Goes Nowhere After FDA Approval"},"content":{"rendered":"\n

(By Phil Galewitz for KFF Health News)<\/p>\n\n\n\n

Nearly a year after the Biden administration gave Florida the green light to become the first state to import lower-cost prescription drugs from Canada \u2014 a longtime goal of politicians across the political spectrum, including President-elect Donald Trump \u2014 the program has yet to begin.<\/p>\n\n\n\n

Florida Gov. Ron DeSantis hailed the FDA\u2019s approval of his plan in January, calling it a victory over the drug industry, which opposes importation on the grounds that it would lead to a surge in counterfeit medications. Continue reading here…<\/a><\/p>\n\n\n\n

Kaiser Health News is a nonprofit national health polity news service that is part of the nonpartisan Henry J. Kaiser Family Foundation<\/p>\n\n\n\n

\"\"<\/p>\n\n\n\n

Notice:<\/strong>\u00a0The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n","protected":false},"excerpt":{"rendered":"

(By Phil Galewitz for KFF Health News) Nearly a year after the Biden administration gave Florida the green light to<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,20,16,6,15],"tags":[1605,1606,76,1607,67,61],"class_list":["post-23664","post","type-post","status-publish","format-standard","hentry","category-fda","category-health-care-redesign","category-medicaid","category-medicare-general","category-part-dprescription-drugs","tag-canadian-drug-import","tag-drug-industry","tag-fda","tag-lower-drug-costs","tag-medicaid","tag-medicare"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/23664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23664"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/23664\/revisions"}],"predecessor-version":[{"id":23665,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/23664\/revisions\/23665"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}